Oral NSAI Versus Paracetamol or Placebo as a Second Line Treatment for Renal Colics

• Status: Recruiting
• Trial end date: 2024-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Outpatients treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this matter.

The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency departement after the first line treatment of a renal colic investigating the recurrence of pain, the reconsultation rates and the admissions.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Monastir
• Treatments: Acetaminophen; Piroxicam

Criteria

Inclusion Criteria:

• Over 16 years old

• Consenting to participate in the study

• Patients treated in the ED for RC

• No contraindications of NSAI treatment

Exclusion Criteria:

• Patients excluded from the first phase of the study

• Contraindication of NSAI treatment

• Patients non reachable by telephone call

• Patients that did not receive or use the treatment